DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (210)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 210   Next >>

Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Asthenia, Escherichia Infection, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Xanax; Benadryl; Metoprolol Tartrate; Vicodin; Protonix



Possible Paclitaxel side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Ranitidine; Granisetron; Dexamethasone; Omeprazole; Perindopril Erbumine; Enoxaparin Sodium; Promethazine



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Lovenox; Xanax; Benadryl; Duoneb; Protonix; Metoprolol; Vicodin



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-13

Patient:

Reactions: Dyspnoea, Brain Natriuretic Peptide Increased, Ejection Fraction Decreased, Nail Disorder, Cardiac Failure Congestive, Infusion Related Reaction

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 40-60 mg/m2 for fac and 60 mg/m2 for ac
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: 500 mg/m2 for fac regimen and 600 mg/m2 for ac regimen
    Indication: Breast Cancer

Docetaxel
    Indication: Breast Cancer

Doxorubicin Hydrochloride
    Dosage: 40-60 mg/m2 for fac and 60 mg/m2 for ac
    Indication: Breast Cancer

Epirubicin
    Dosage: 75-100 mg/m2
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Trastuzumab
    Dosage: 8 mg/kg followed by maintenance (md) 6 mg/kg every 3 wks or 4 mg/kg followed by 2 mg/kg weekly md
    Indication: Breast Cancer



Possible Paclitaxel side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-09

Patient:

Reactions: Brain Natriuretic Peptide Increased, Dyspnoea, Ejection Fraction Decreased, Nail Disorder, Cardiac Failure Congestive, Infusion Related Reaction

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 mg/m2 for fac regimen and 600 mg/m2 for ac regimen
    Indication: Breast Cancer

Docetaxel
    Indication: Breast Cancer

Doxorubicin Hydrochloride
    Dosage: 40-60 mg/m2 for fac and 60 mg/m2 for ac
    Indication: Breast Cancer

Epirubicin
    Dosage: 75-100 mg/m2
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Trastuzumab
    Dosage: 8 mg/kg followed by maintenance (md) 6 mg/kg every 3 wks or 4 mg/kg followed by 2 mg/kg weekly md
    Indication: Breast Cancer



Possible Paclitaxel side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-06

Patient: 38 year old female

Reactions: Dyspnoea, Hypersensitivity, Arthralgia, Hypotension, Cyanosis Central

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Paclitaxel



Possible Paclitaxel side effects in 55 year old female

Reported by a pharmacist from Singapore on 2012-08-05

Patient: 55 year old female

Reactions: Lung Disorder, Chest Discomfort, Dyspnoea, Condition Aggravated

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Ranitidine; Diphenhydramine Hydrochloride; Dexamethasone Sodium Phosphate



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-02

Patient: female, weighing 110.1 kg (242.2 pounds)

Reactions: Dyspnoea, Chest Pain, Tachycardia, Dehydration, Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 800 mg

Paclitaxel
    Dosage: 380 mg



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Pyrexia, Multi-Organ Failure, Oedema, Hypoxia, Urosepsis, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Vicodin; Protonix; Lovenox; Duoneb; Metoprolol Tartrate; Xanax; Benadryl



Possible Paclitaxel side effects in 35 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-08-01

Patient: 35 year old female, weighing 58.0 kg (127.6 pounds)

Reactions: Dyspnoea, Anaphylactic Shock, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Anaemia, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Acute Respiratory Distress Syndrome, Oedema, Hypoxia, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Metoprolol Tartrate; Xanax; Vicodin; Benadryl; Protonix



Possible Paclitaxel side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 73 year old male, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Enoxaparin Sodium; Ranitidine; Granisetron; Omeprazole; Promethazine; Dexamethasone; Perindopril Erbumine



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Hypoxia, Urosepsis, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Vicodin; Xanax; Metoprolol Tartrate; Benadryl; Protonix



Possible Paclitaxel side effects in 74 year old male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: 74 year old male, weighing 131.0 kg (288.2 pounds)

Reactions: Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Micardis; Panamax; Motilium; Panamax; Allopurinol; Esomeprazole; Lorazepam; Bisoprolol Fumarate; Motilium; Novolog MIX 70 / 30; Furosemide; Bisoprolol Fumarate; Micardis



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: female, weighing 100.9 kg (222.0 pounds)

Reactions: Abdominal Pain, Dyspnoea, Chills, Wound Infection, Hyperhidrosis, Erythema, Incision Site Pain, Culture Wound Positive, Leukocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
G-CSF (Filgrastim, Amgen) 6 MG
    Dosage: 6 mg

Ifosfamide
    Dosage: 9600 mg

Paclitaxel
    Dosage: 270 mg



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Xanax; Metoprolol Tartrate; Vicodin; Benadryl; Protonix; Duoneb; Lovenox



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-11

Patient: female, weighing 49.0 kg (107.8 pounds)

Reactions: Pneumonia, Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-03-19

Carboplatin
    Start date: 2012-06-25

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-03-19

Doxorubicin HCL
    Start date: 2012-05-03

Lapatinib
    Dosage: 500 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-19

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-03-19

Paclitaxel
    Start date: 2012-06-25

Trastuzumab
    Start date: 2012-05-03

Trastuzumab
    Indication: Breast Cancer
    Start date: 2012-03-19

Other drugs received by patient: Filgrastim



Possible Paclitaxel side effects in 58 year old male

Reported by a pharmacist from Brazil on 2012-07-06

Patient: 58 year old male, weighing 48.8 kg (107.4 pounds)

Reactions: Back Pain, Abdominal Discomfort, Flushing, Dyspnoea, Tachycardia

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Ranitidine; Cisplatin; Metoclopramide; Diphenhydramine HCL; Ondansetron; Dexamethasone Sodium Phosphate



Possible Paclitaxel side effects in 62 year old female

Reported by a pharmacist from Canada on 2012-07-05

Patient: 62 year old female, weighing 71.6 kg (157.5 pounds)

Reactions: Dyspnoea, Throat Tightness

Drug(s) suspected as cause:
Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-06-21

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-07-12
    End date: 2011-07-12



Possible Paclitaxel side effects in 79 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: 79 year old female

Reactions: Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dasatinib
    Dosage: last dose on:26jun12
    Indication: Breast Cancer Metastatic
    Start date: 2012-04-19

Estramustine
    Dosage: last dose on:26jun12
    Indication: Breast Cancer
    Start date: 2012-04-19

Paclitaxel
    Dosage: last dose on:26jun12
    Indication: Breast Cancer Metastatic
    Start date: 2012-04-19

Other drugs received by patient: Ascorbic Acid; Calcium + Vitamin D; Levothyroxine Sodium; Fentanyl; Vitamin D; Docusate Sodium; Senna-Mint WAF



Possible Paclitaxel side effects in 74 year old male

Reported by a consumer/non-health professional from United States on 2012-07-04

Patient: 74 year old male, weighing 131.0 kg (288.2 pounds)

Reactions: Dyspnoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Novolog MIX 70 / 30; Allopurinol; Micardis; Panamax; Panamax; Micardis; Motilium; Lorazepam; Bisoprolol Fumarate; Bisoprolol Fumarate; Furosemide; Esomeprazole; Motilium



Possible Paclitaxel side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28

Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)

Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure

Drug(s) suspected as cause:
(Domperidone)
    Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chlorpheniramine Maleate
    Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg milligram(s) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg milligram(s), 1 day, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg milligram(s) subcutaneous
    Indication: Chemotherapy

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: see image
    Indication: Breast Cancer
    End date: 2011-07-05

Ranitidine
    Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: (Docusate); (Biotene / 00203502 / )



Possible Paclitaxel side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-28

Patient: 59 year old female

Reactions: Blood Pressure Increased, Generalised Erythema, Dyspnoea, Cough

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Solu-Cortef; Ondansetron (Zofran); Doxorubicin HCL; Chlorpheniramine TAB



Possible Paclitaxel side effects in 57 year old female

Reported by a physician from United States on 2012-06-26

Patient: 57 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Small Intestinal Obstruction, Abdominal Pain, Dyspnoea, Vision Blurred, Gastric Haemorrhage, Cerebral Ischaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aspirin

Bevacizumab
    Dosage: frequency: over 30-90 min on day 01; cycle: 21 daystotal dose: 1350 mg
    Start date: 2009-04-06

Carboplatin
    Dosage: auc 05 over 30 min on day 01; cycle: 21 days
    Start date: 2009-04-06

Docetaxel
    Dosage: frequency: over 01 hour on day 01; cycle: 21 days.
    Start date: 2009-04-06

Paclitaxel
    Dosage: frequency: over 03 hours on day 01; cycle: 21 days
    Start date: 2009-04-06



Possible Paclitaxel side effects in 48 year old female

Reported by a pharmacist from United Kingdom on 2012-06-25

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Fatigue, Chest Discomfort, Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Dosage: 10 mg, unk, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg, iv
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone (Domperidone)
    Dosage: 20 mg, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Dosage: 1 mg, bid, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315;300 mg, qow, iv
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Paclitaxel
    Dosage: 315;300 mg, qow, iv
    Indication: Breast Cancer
    End date: 2011-07-05

Pegfilgrastim (Pegfilgrastim)
    Dosage: 6 mg, sc
    Indication: Product Used FOR Unknown Indication

Ranitidine Hydrochloride
    Dosage: 50 mg, iv
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Biotene; Doxorubicin HCL; Cyclophosphamide; Docusate



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-22

Patient: female

Reactions: Abdominal Pain, Death, Dyspnoea, Tachycardia, Cardiogenic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Paclitaxel

Other drugs received by patient: Zofran; Dexamethasone Sodium Phosphate; Zantac; Trimeton



Possible Paclitaxel side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22

Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue

Drug(s) suspected as cause:
Chlorpheniramine TAB
    Indication: Product Used FOR Unknown Indication

Dexamethasone

Dexamethasone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Granisetron
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Neulasta
    Indication: Chemotherapy

Paclitaxel
    End date: 2011-07-05

Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-07-05

Ranitidine
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene



Possible Paclitaxel side effects in 77 year old female

Reported by a physician from United States on 2012-06-22

Patient: 77 year old female, weighing 96.4 kg (212.1 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Fall, HIP Fracture, Fatigue, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: last dos eprior to sae 22 feb 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01

Carboplatin
    Dosage: last dos eprior to sae 5 apr 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01

Paclitaxel
    Dosage: last dos eprior to sae 5 apr 2012
    Indication: Ovarian Cancer
    Start date: 2012-02-01



Possible Paclitaxel side effects in 49 year old female

Reported by a pharmacist from United Kingdom on 2012-06-21

Patient: 49 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Respiratory Depth Decreased, Fatigue, Dyspnoea, Chest Discomfort, Chest Pain

Drug(s) suspected as cause:
Chlorphenamine
    Dosage: 10 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 20 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Dexamethasone
    Dosage: 4 mg, 2x/day
    Administration route: Oral

Domperidone
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Domperidone
    Dosage: 20mg, daily
    Administration route: Oral

Granisetron
    Dosage: 1 mg, 2x/day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Dosage: 315 mg, every two weeks
    Indication: Breast Cancer
    Start date: 2011-05-24
    End date: 2011-06-07

Paclitaxel
    Dosage: 300 mg, every 2 weeks
    Start date: 2011-06-21
    End date: 2011-07-05

Pegfilgrastim
    Dosage: 6 mg, 1x/day
    Indication: Chemotherapy

Ranitidine
    Dosage: 50 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Docusate; Biotene Mouthwash



Possible Paclitaxel side effects in 57 year old female

Reported by a individual with unspecified qualification from United States on 2012-06-21

Patient: 57 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Small Intestinal Obstruction, Abdominal Pain, Dyspnoea, Vision Blurred, Gastric Haemorrhage, Cerebral Ischaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aspirin
    Indication: Product Used FOR Unknown Indication

Avastin
    Dosage: cycle= 21 days; over 30-90 min on day 01, total dose: 1350 mg, last date administered: 8 march 2011
    Indication: Neoplasm Malignant

Carboplatin
    Dosage: auc 05 over 30 min on day 01; cycle=21 days, total dose: 467 mg, last dose administered: 31 july 201
    Indication: Neoplasm Malignant

Docetaxel
    Dosage: over 01 hour on day 01; cycle=21 days
    Indication: Neoplasm Malignant

Paclitaxel
    Dosage: over 03 hours on day 01; cycle=21 days, total dose: 175 mg, last administered: 31 july 2011
    Indication: Neoplasm Malignant



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017